此外,本月有知情人士爆料称,阿斯利康也在积极准备竞购Onyx制药,这将使阿斯利康获得数个抗癌药物,包括血癌治疗药物Kyprolis。彭博社本月22日报道称,辉瑞(Pfizer)、诺华(Novartis)也在准备竞标Onyx制药,同时安进(Amgen)也仍然有兴趣收购Onyx制药。此前...查看全文
Hulu2013-08-16 07:11
$Onyx Pharmaceuticals(ONXX)$
上月安进(Amgen)向Onyx Pharmaceuticals主动发出的100亿美元收购提议。查看全文
医药邦at壹专家2013-07-05 12:34
$Onyx Pharmaceuticals(ONXX)$ 给A正见回学习……WASHINGTON--The Securities and Exchange Commission has frozen the assets of a group of unnamed traders who earned $4.6 million in potentially illegal profits by trading Onyx Pharmaceuticals Inc. (ONXX) before the cancer drug-maker...查看全文
方舟882012-01-13 17:09
【高盛集团发布报告预测今年最有可能被收购的几家公司】
$Dendreon(DNDN)$公司:2011年9月,该公司因前列腺癌疫苗Provenge销售不如预期而裁员25%。尽管Provenge是在美国批准用于治疗前列腺癌的首只免疫产品,但由于93000美元高昂的价格和支付问题,导致销量不佳。
$人类基因组科学(HGSI)$...查看全文
内部交易: $Onyx Pharmaceuticals(ONXX)$ 2013-05-06,Director,WIGGANS THOMAS G ,卖出,4500普通股, $91.01
内部交易: $Onyx Pharmaceuticals(ONXX)$ 2013-05-06,Director,WIGGANS THOMAS G ,期权,4500普通股, $26.34
内部交易: $Onyx Pharmaceuticals(ONXX)$ 2013-05-07,EVP, GC and Corp. Secretary,SHEMA SUZANNE M ,卖出,4051普通股, $89.97
内部交易: $Onyx Pharmaceuticals(ONXX)$ 2013-05-07,EVP, GC and Corp. Secretary,SHEMA SUZANNE M ,期权,4051普通股, $34.30
内部交易: $Onyx Pharmaceuticals(ONXX)$ 2013-05-08,Director,GODDARD PAUL ,卖出,1000普通股, $95.00
内部交易: $Onyx Pharmaceuticals(ONXX)$ 2013-05-08,Director,GODDARD PAUL ,期权,1000普通股, $28.41
内部交易: $Onyx Pharmaceuticals(ONXX)$ 2013-05-07,SVP, Global Human Resources,Foster-Cheek Kaye I ,卖出,8877普通股, $89.84
内部交易: $Onyx Pharmaceuticals(ONXX)$ 2013-05-07,SVP, Global Human Resources,Foster-Cheek Kaye I ,期权,8877普通股, $31.15
内部交易: $Onyx Pharmaceuticals(ONXX)$ 2013-05-01,Director,GODDARD PAUL ,卖出,5000普通股, $93.02
内部交易: $Onyx Pharmaceuticals(ONXX)$ 2013-05-01,Director,GODDARD PAUL ,期权,5000普通股, $15.68